nafazatrom has been researched along with maitotoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Judd, AM; Koike, K; Login, IS; MacLeod, RM; Yasumoto, T | 1 |
| Ehreth, JT; Judd, AM; Login, IS; MacLeod, RM | 1 |
2 other study(ies) available for nafazatrom and maitotoxin
| Article | Year |
|---|---|
Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Indomethacin; Ion Channels; Marine Toxins; Oxocins; Pituitary Neoplasms; Prolactin; Prostaglandins; Pyrazoles; Pyrazolones; Rats; SRS-A | 1986 |
Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release.
Topics: Animals; Female; Fibrinolytic Agents; Growth Hormone; In Vitro Techniques; Marine Toxins; Oxocins; Prolactin; Pyrazoles; Pyrazolones; Radioimmunoassay; Rats; Rats, Inbred Strains; Thyrotropin | 1986 |